Predictive Technology Group, Inc. (PREDQ)

Market Cap	317.00 -99.7%
Revenue (ttm)	19.17M -44.9%
Net Income	-68.15M
EPS	-0.23
Shares Out	316.67M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	748,582
Average Volume	18,479
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	-0.35
RSI	47.42
Earnings Date	n/a

About PREDQ

Predictive Technology Group, Inc., together with its subsidiaries, develops and commercializes discoveries and technologies involved in novel molecular diagnostic, therapeutic, and human cellular and tissue-based products (HCT/Ps). It operates in two segments, Human Cellular and Tissues Products (HCT/Ps); and Diagnostics and Therapeutics. The company provides FertilityDX, a genetic testing service for couples experiencing infertility; ARTguide, a genetic test for women experiencing infertility because of endometriosis and other genetic conditio...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2005
• Employees: 64
• Stock Exchange: OTCMKTS
• Ticker Symbol: PREDQ

Financial Performance

In fiscal year 2020, PREDQ's revenue was $24.44 million, a decrease of -43.80% compared to the previous year's $43.49 million. Losses were -$85.77 million, 460.4% more than in 2019.